Treatment response to idelalisib in a patient with immunodeficiency-associated Burkitt lymphoma harboring a PIK3CA H1047R mutation

Detalles Bibliográficos
Autores principales: Bleckmann, Annalen, Dierks, Sascha, Schildhaus, Hans-Ulrich, Hellige, Niels, Bacher, Ulrike, Trümper, Lorenz, Wulf, Gerald
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2020
Materias:
Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7782442/
https://www.ncbi.nlm.nih.gov/pubmed/32193631
http://dx.doi.org/10.1007/s00277-020-03974-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7782442/
https://www.ncbi.nlm.nih.gov/pubmed/32193631
http://dx.doi.org/10.1007/s00277-020-03974-y

Ejemplares similares